Abstract:In this study, we prepare chiral D-/L-type Se@CeO2 superparticles (D-/L-SPs) with a g-factor of 0.018 using D-/L-cysteine as chiral ligands. The chiral SPs demonstrate ultra-high enzyme activity of peroxidase (POD), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx). Due to the synergistic effect between Se and CeO2, the maximum initial velocity of GPx, CAT, and POD for L-SP is 10, 7, and 5.6 times higher than that of a mixture of Se nanoparticles (NPs) and CeO2 NPs. Significantly, the chiral L-SPs show much stronger ROS scavenging ability than D-SP in the PD-like cell model. Moreover, the amount of α-synuclein (α-syn) in the cerebrospinal fluid of PD mice is reduced by 70.7% within two weeks. The L-SPs effectively alleviate neurodegeneration in a mouse model of PD, showing potential applications in the clinical treatment of neurodegenerative diseases.

Correction: Chiral Se@CeO 2 superparticles for ameliorating Parkinson's disease

Chiral Se@CeO2 Superparticles Ameliorating Parkinson's Disease

Correction: Nanorod-associated plasmonic circular dichroism monitors the handedness and composition of α-synuclein fibrils from Parkinson's disease models and post-mortem brain

Correction: Enhanced Photoluminescence of Silicon Quantum Dots in the Presence of Both Energy Transfer Enhancement and Emission Enhancement Mechanisms Assisted by the Double Plasmon Modes of Gold Nanorods

Correction: Shape-controlled Synthesis of Porous Co3O4 Nanostructures for Application in Supercapacitors

Correction: Facile Preparation of Phospholipid-Amorphous Calcium Carbonate Hybrid Nanoparticles: Toward Controllable Burst Drug Release and Enhanced Tumor Penetration.

Correction: Copper coordination-based conjugated polymer nanoparticles for synergistic photodynamic and chemodynamic therapy

Author Correction: Reversing a model of Parkinson’s disease with in situ converted nigral neurons

Correction: Celery-derived porous carbon materials for superior performance supercapacitors

Correction: Ordered nanoparticle arrays interconnected by molecular linkers: electronic and optoelectronic properties.

Correction: Application of Carbon-Based Nanomaterials in Alzheimer's Disease.

Correction: Synthesis of heteroleptic phosphine–copper( i ) complexes: fluorescence sensing and catalytic properties

Corrigendum: Uncovering the Pharmacology of Ginkgo Biloba Folium in the Cell-Type-specific Targets of Parkinson’s Disease with a Deep Learning Algorithm

Author correction to ‘A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer’s disease’ [Acta Pharmaceutica Sinica B 12 (2021) 4032‒4044]

Correction: Gadolinium-doped carbon dots with high-performance in dual-modal molecular imaging

Correction: Polyaniline nanorods dotted on graphene oxide nanosheets as a novel super adsorbent for Cr(vi)

Correction: Large-scale synthesis of ultrafine Fe 3 C nanoparticles embedded in mesoporous carbon nanosheets for high-rate lithium storage

Correction: Synthesis of lead-free Cs 3 Sb 2 Br 9 perovskite alternative nanocrystals with enhanced photocatalytic CO 2 reduction activity

Correction: Nanoporous hybrid CuO/ZnO/carbon papers used as ultrasensitive non-enzymatic electrochemical sensors

Correction: Synthesis of porous Fe 3 O 4 hollow microspheres/graphene oxide composite for Cr(vi) removal

Correction: Shape-controlled synthesis of micro-/nanosized Cu particles with spherical and polyhedral shapes using the polyol process